Literature DB >> 25022969

The expression of cytokines and chemokines in the blood of patients with severe weight loss from anorexia nervosa: an exploratory study.

D S Pisetsky1, S E Trace2, K A Brownley3, R M Hamer4, N L Zucker5, P Roux-Lombard6, J-M Dayer7, C M Bulik8.   

Abstract

Anorexia nervosa (AN) is a serious, potentially life-threatening disorder characterized by severe weight loss, dysregulated eating, and often excessive exercise. While psychiatric illnesses such as depression are associated with increased levels of pro-inflammatory mediators, evidence for such disturbances in patients with AN has been less clear. In an exploratory study of possible disturbances in immune responses in AN, we assayed a panel of cytokines and chemokines in the blood of patients undergoing inpatient treatment, testing the hypothesis that metabolic disturbances in this disease would lead to a pattern of immune disturbances distinct from that of other psychiatric diseases. For this purpose, we evaluated patients by the Beck Depression Inventory-II (BDI-II) and the Eating Disorders Examination-Questionnaire and assessed cytokines and chemokines by enzyme-linked immunosorbent assays. Patients reported a moderate level of depression (mean BDI-II = 22.6) but exhibited few immunologic abnormalities of the kind associated with major depressive disorder [e.g., increased interleukin (IL)-6]; RANTES showed the most frequent elevations and was increased in 4 of the patients studied. Together, these findings suggest that features of AN such as loss of adipose tissue and excessive exercise may attenuate cytokine production and thus modulate the experience of illness that impacts on core features of disease.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anorexia nervosa; Chemokines; Cytokines; Depression; Eating disorder

Mesh:

Substances:

Year:  2014        PMID: 25022969      PMCID: PMC4411080          DOI: 10.1016/j.cyto.2014.05.018

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  67 in total

Review 1.  RANTES: a versatile and controversial chemokine.

Authors:  V Appay; S L Rowland-Jones
Journal:  Trends Immunol       Date:  2001-02       Impact factor: 16.687

2.  Long-term outcome of anorexia nervosa in a prospective 21-year follow-up study.

Authors:  B Löwe; S Zipfel; C Buchholz; Y Dupont; D L Reas; W Herzog
Journal:  Psychol Med       Date:  2001-07       Impact factor: 7.723

3.  The albumin-nutrition connection: separating myth from fact.

Authors:  M Patricia Fuhrman
Journal:  Nutrition       Date:  2002-02       Impact factor: 4.008

4.  Metabolic abnormalities in adolescent patients with anorexia nervosa.

Authors:  M R Milner; E R McAnarney; W J Klish
Journal:  J Adolesc Health Care       Date:  1985-05

5.  Plasma concentrations of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, and of their soluble receptors and receptor antagonist in anorexia nervosa.

Authors:  F Brambilla; D Monti; C Franceschi
Journal:  Psychiatry Res       Date:  2001-09-20       Impact factor: 3.222

6.  Evidence for a positive correlation between serum cortisol levels and IL-1beta production by peripheral mononuclear cells in anorexia nervosa.

Authors:  P Limone; A Biglino; F Bottino; B Forno; P Calvelli; S Fassino; C Berardi; P Ajmone-Catt; A Bertagna; R P Tarocco; G G Rovera; G M Molinatti
Journal:  J Endocrinol Invest       Date:  2000 Jul-Aug       Impact factor: 4.256

7.  Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity.

Authors:  N C Raymond; M Dysken; K Bettin; E D Eckert; S J Crow; K Markus; C Pomeroy
Journal:  Int J Eat Disord       Date:  2000-11       Impact factor: 4.861

8.  Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa.

Authors:  Kai G Kahl; Nils Kruse; Peter Rieckmann; Martin H Schmidt
Journal:  Psychoneuroendocrinology       Date:  2004-01       Impact factor: 4.905

9.  Pain sensitivity in anorexia nervosa and bulimia nervosa.

Authors:  S Lautenbacher; A M Pauls; F Strian; K M Pirke; J C Krieg
Journal:  Biol Psychiatry       Date:  1991-06-01       Impact factor: 13.382

10.  Biochemical abnormalities of the serum in anorexia nervosa.

Authors:  S Umeki
Journal:  J Nerv Ment Dis       Date:  1988-08       Impact factor: 2.254

View more
  16 in total

1.  Eating Disorders, Autoimmune, and Autoinflammatory Disease.

Authors:  Stephanie Zerwas; Janne Tidselbak Larsen; Liselotte Petersen; Laura M Thornton; Michela Quaranta; Susanne Vinkel Koch; David Pisetsky; Preben Bo Mortensen; Cynthia M Bulik
Journal:  Pediatrics       Date:  2017-11-09       Impact factor: 7.124

Review 2.  Reconceptualizing anorexia nervosa.

Authors:  Cynthia M Bulik; Rachael Flatt; Afrouz Abbaspour; Ian Carroll
Journal:  Psychiatry Clin Neurosci       Date:  2019-07-01       Impact factor: 5.188

3.  Persimmon vinegar ripening with the mountain-cultivated ginseng ingestion reduces blood lipids and lowers inflammatory cytokines in obese adolescents.

Authors:  Hyobin Seo; Byung-Duk Jeon; Sungpil Ryu
Journal:  J Exerc Nutrition Biochem       Date:  2015-03-31

4.  A role for intestinal TLR4-driven inflammatory response during activity-based anorexia.

Authors:  Liliana Belmonte; Najate Achamrah; Séverine Nobis; Charlène Guérin; Gaëtan Riou; Christine Bôle-Feysot; Olivier Boyer; Vincent Richard; Jean Claude Do Rego; Pierre Déchelotte; Alexis Goichon; Moïse Coëffier
Journal:  Sci Rep       Date:  2016-10-25       Impact factor: 4.379

Review 5.  Immune disorders in anorexia.

Authors:  Sylwia Małgorzata Słotwińska; Robert Słotwiński
Journal:  Cent Eur J Immunol       Date:  2017-10-30       Impact factor: 2.085

Review 6.  Cutaneous melanoma dissemination is dependent on the malignant cell properties and factors of intercellular crosstalk in the cancer microenvironment (Review).

Authors:  Ondřej Kodet; Jan Kučera; Karolína Strnadová; Barbora Dvořánková; Jiří Štork; Lukáš Lacina; Karel Smetana
Journal:  Int J Oncol       Date:  2020-06-26       Impact factor: 5.650

7.  Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample.

Authors:  Teresa A Victor; Sahib S Khalsa; W Kyle Simmons; Justin S Feinstein; Jonathan Savitz; Robin L Aupperle; Hung-Wen Yeh; Jerzy Bodurka; Martin P Paulus
Journal:  BMJ Open       Date:  2018-01-24       Impact factor: 2.692

Review 8.  Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis.

Authors:  S P Leighton; L Nerurkar; R Krishnadas; C Johnman; G J Graham; J Cavanagh
Journal:  Mol Psychiatry       Date:  2017-11-14       Impact factor: 15.992

9.  Alterations of proteome, mitochondrial dynamic and autophagy in the hypothalamus during activity-based anorexia.

Authors:  Séverine Nobis; Alexis Goichon; Najate Achamrah; Charlène Guérin; Saida Azhar; Philippe Chan; Aline Morin; Christine Bôle-Feysot; Jean Claude do Rego; David Vaudry; Pierre Déchelotte; Liliana Belmonte; Moïse Coëffier
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

10.  The effect of trauma and alcohol on the relationship between level of cytokines and depression among patients entering psychiatric treatment.

Authors:  Helge Toft; Sudan Prasad Neupane; Jørgen G Bramness; Terje Tilden; Bruce E Wampold; Lars Lien
Journal:  BMC Psychiatry       Date:  2018-04-10       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.